KOCHI: Havildar K G George, a Vir Chakra awardee from the 1965 Indo-Pak war and the last living Vir Chakra recipient from the Corps of Signals, passed away Satu ...

Vir Biotechnology, Inc. ( VIR) Q4 2025 Earnings Call February 23, 2026 5:30 PM EST ...

The 1,064-horsepower ZR1 broke the seven-year old production car lap record set by one of Europe's premier supercars, the ...

Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s prostate cancer candidate VIR-5500 through a collaboration that could generate more than $1.7 billion for the San ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that members of the management team will participate in the following investor conferences during the month of March:TD Cowen 46th Annual Health ...

Chevrolet is celebrating one of the most incredible records in automotive history. The Chevrolet Corvette ZR1 just set the ...

Vir secured $335 million in upfront and near-term payments from its global collaboration with Astellas to advance VIR-5500.

While Vir Biotech is best known for its work on infectious diseases, its developing cancer pipeline has delivered a partnership with Astellas that could be worth around $1.4 billion.

The consensus estimate for Q4 2025 revenue is $23.18 million, and the earnings are expected to come in at -$0.41 per share. The full year 2025's revenue is expected to be $19.22 million, and the ...

Detailed price information for Vir Biotechnology Inc (VIR-Q) from The Globe and Mail including charting and trades.

Hims & Hers Health guided for lower-than-expected revenue in the first quarter. The stock declined 6.6% to $14.48 after the bell. Vir Biotechnology signed a $335 million licensing deal for its ...